| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.051 | 0.4 |